These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 15289848

  • 1. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease.
    Singal R, Ferdinand L, Reis IM, Schlesselman JJ.
    Oncol Rep; 2004 Sep; 12(3):631-7. PubMed ID: 15289848
    [Abstract] [Full Text] [Related]

  • 2. Multigene methylation analysis for detection and staging of prostate cancer.
    Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R.
    Clin Cancer Res; 2005 Sep 15; 11(18):6582-8. PubMed ID: 16166436
    [Abstract] [Full Text] [Related]

  • 3. Gene promoter methylation in prostate tumor-associated stromal cells.
    Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, Tangrea JA, Libutti SK, Linehan WM, Woodson KG.
    J Natl Cancer Inst; 2006 Feb 15; 98(4):255-61. PubMed ID: 16478744
    [Abstract] [Full Text] [Related]

  • 4. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
    Zöchbauer-Müller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD.
    Cancer Res; 2001 Jan 01; 61(1):249-55. PubMed ID: 11196170
    [Abstract] [Full Text] [Related]

  • 5. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
    Zon G, Barker MA, Kaur P, Groshen S, Jones LW, Imam SA, Boyd VL.
    Anal Biochem; 2009 Sep 15; 392(2):117-25. PubMed ID: 19505431
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.
    Bastian PJ, Ellinger J, Wellmann A, Wernert N, Heukamp LC, Müller SC, von Ruecker A.
    Clin Cancer Res; 2005 Jun 01; 11(11):4097-106. PubMed ID: 15930345
    [Abstract] [Full Text] [Related]

  • 7. Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features.
    Maruyama R, Toyooka S, Toyooka KO, Virmani AK, Zöchbauer-Müller S, Farinas AJ, Minna JD, McConnell J, Frenkel EP, Gazdar AF.
    Clin Cancer Res; 2002 Feb 01; 8(2):514-9. PubMed ID: 11839671
    [Abstract] [Full Text] [Related]

  • 8. Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation.
    Padar A, Sathyanarayana UG, Suzuki M, Maruyama R, Hsieh JT, Frenkel EP, Minna JD, Gazdar AF.
    Clin Cancer Res; 2003 Oct 15; 9(13):4730-4. PubMed ID: 14581343
    [Abstract] [Full Text] [Related]

  • 9. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
    Cho NY, Kim BH, Choi M, Yoo EJ, Moon KC, Cho YM, Kim D, Kang GH.
    J Pathol; 2007 Feb 15; 211(3):269-77. PubMed ID: 17139617
    [Abstract] [Full Text] [Related]

  • 10. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.
    Jerónimo C, Varzim G, Henrique R, Oliveira J, Bento MJ, Silva C, Lopes C, Sidransky D.
    Cancer Epidemiol Biomarkers Prev; 2002 May 15; 11(5):445-50. PubMed ID: 12010858
    [Abstract] [Full Text] [Related]

  • 11. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES, Issa JP, Roberts DB, Williams MD, Weber RS, Kies MS, El-Naggar AK.
    Clin Cancer Res; 2008 May 01; 14(9):2664-72. PubMed ID: 18451230
    [Abstract] [Full Text] [Related]

  • 12. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
    Bastian PJ, Ellinger J, Schmidt D, Wernert N, Wellmann A, Müller SC, von Rücker A.
    Eur J Med Res; 2004 Nov 29; 9(11):523-7. PubMed ID: 15649863
    [Abstract] [Full Text] [Related]

  • 13. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB, Saboorian MH, Ashfaq R, Toyooka KO, Toyooka S, Minna JD, Gazdar AF, Schorge JO.
    Clin Cancer Res; 2005 Aug 01; 11(15):5365-9. PubMed ID: 16061849
    [Abstract] [Full Text] [Related]

  • 14. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
    Rosenbaum E, Hoque MO, Cohen Y, Zahurak M, Eisenberger MA, Epstein JI, Partin AW, Sidransky D.
    Clin Cancer Res; 2005 Dec 01; 11(23):8321-5. PubMed ID: 16322291
    [Abstract] [Full Text] [Related]

  • 15. Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis.
    Gonzalgo ML, Nakayama M, Lee SM, De Marzo AM, Nelson WG.
    Urology; 2004 Feb 01; 63(2):414-8. PubMed ID: 14972513
    [Abstract] [Full Text] [Related]

  • 16. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids.
    Goessl C, Krause H, Müller M, Heicappell R, Schrader M, Sachsinger J, Miller K.
    Cancer Res; 2000 Nov 01; 60(21):5941-5. PubMed ID: 11085508
    [Abstract] [Full Text] [Related]

  • 17. Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma.
    Enokida H, Shiina H, Urakami S, Terashima M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Igawa M, Dahiya R.
    Cancer; 2006 Jan 01; 106(1):79-86. PubMed ID: 16323173
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Polymorphisms in the DNA methyltransferase 3b gene and prostate cancer risk.
    Singal R, Das PM, Manoharan M, Reis IM, Schlesselman JJ.
    Oncol Rep; 2005 Aug 01; 14(2):569-73. PubMed ID: 16012746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.